RE: Should be much higher5 Dec 2024 13:53
There is lots more to come, let’s not forget…the massive grant, is only one string to their bow, they’re working on other key things like:
💥- partnership with USA national cancer institute
💥- developed multiple class leading proprietary technologies which could be licensed/bought out
💥- working with Oxford uni to develop their own AI algorithms
💥- contracts with leading global diagnostic companies for ongoing supply
💥- repurposing their tech generating 2-30x yield improvements for clients existing valuable antibody assets
💥- multiple milestone and royalty interests for antibodies being developed around the world
Many booms to come!